REVIEW OF CHRONIC KIDNEY DISEASE IN CLINICAL PRACTICE
Keywords:
CKD, etiology, diagnosis, diabetic kidney disease, sodium–glucose co-transporter 2 inhibitorsAbstract
Early detection is a critical strategy for preventing kidney disease, its progression, and related problems, yet multiple studies have found that public knowledge of renal illness is poor. Thus, expanding information and adopting long-term solutions for early diagnosis of kidney illness are public health priority. Economic and epidemiological data highlight why kidney illness should be prioritized on the global public health agenda: kidney disease prevalence is rising internationally, and it is now the seventh highest risk factor for mortality. Furthermore, demographic trends, the obesity epidemic, and the consequences of climate change are all expected to increase kidney disease prevalence even more, with major implications for survival, quality of life, and health-care spending around the world[1]. Importantly, the burden of kidney disease is largest in historically disadvantaged people, who frequently lack access to appropriate renal disease medications, contributing significantly to present socioeconomic gaps in health outcomes.
References
Tuot DS, Wong KK, Velasquez A, et al. CKD awareness in the general population: performance of CKD-specific questions. Kidney Med. 2019;1(2): 43–50.
Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010;17(3):225–36.
Levey AS, Coresh J, Bolton K, et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6): 2089–100.
Darlington O, Dickerson C, Evans M, et al. Costs and healthcare resource use associated with risk of cardiovascular morbidity in patients with chronic kidney Disease: evidence from a systematic literature review. Adv Ther. 2021;38(2):994–1010.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.
Tonelli M, Muntner P, Lloyd A, et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011;154(1): 12–21.
